首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1407389

靜脈設備市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，細分類型（按最終用戶地區和競爭）

Intravenous Equipment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented Type, By End-User Region and Competition

出版日期: 2023年11月07日 | 出版商:

TechSci Research | 英文 178 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2022 年全球靜脈 (IV) 設備市場價值為 135.7 億美元，預計在預測期內將強勁成長，到 2028 年CAGR為5.27%。全球靜脈(IV) 設備市場是一個充滿活力且快速發展的產業在更廣泛的醫療保健產業中，在病患照護和治療中發揮關鍵作用。靜脈治療涉及透過靜脈將液體、藥物和營養物質直接注入血液，相應的設備包括旨在促進此過程的各種裝置。該市場的特點是，由於慢性病盛行率不斷上升、人口老化以及全球外科手術數量不斷增加，對創新和先進靜脈注射設備的需求不斷成長。

促進全球靜脈設備市場成長的關鍵因素包括糖尿病、癌症和心血管疾病等疾病發生率的不斷上升，因此需要高效、精確的藥物傳遞機制。隨著世界各地的醫療保健系統專注於改善患者的治療效果和盡量減少住院時間，對靜脈注射療法的需求激增。此外，智慧幫浦、安全輸液系統和無線連接等靜脈注射設備的技術進步提高了給藥的準確性和安全性，進一步推動了市場的擴張。

市場分為不同的產品類別，包括靜脈導管、輸液幫浦、靜脈注射溶液和配件。靜脈導管對於建立安全的血管接入點至關重要，它正在見證旨在減少併發症和提高患者舒適度的創新。輸液幫浦對於液體和藥物的受控和精確輸送至關重要，在連接性、攜帶性和使用者介面方面正在經歷顯著增強。靜脈注射液由生理食鹽水到特殊藥物等各種液體組成，由於它們在患者水合和藥物管理中發揮重要作用，因此需求量不斷增加。

市場概況
預測期	2024-2028
2022 年市場規模	135.7億美元
2028 年市場規模	182.9億美元
2023-2028 年CAGR	5.27%
成長最快的細分市場	亞太地區
最大的市場	北美洲

主要市場促進因素

市場規模及預測
- 按價值
市佔率及預測
- 依類型（IV 導管、輸液幫浦、固定裝置、給藥裝置、滴注室、其他類型）
- 按最終使用者（醫院、門診手術中心、其他最終使用者）
- 按地區
- 按公司分類 (2022)
市場地圖
- 按類型
- 按最終用戶
- 按地區

第 5 章：亞太地區靜脈 (IV) 設備市場展望

市場規模及預測
- 按價值
市佔率及預測
- 按類型
- 按最終用戶
- 按國家/地區
亞太地區：國家分析
- 中國靜脈（IV）設備
- 印度靜脈 (IV) 設備
- 澳洲靜脈 (IV) 設備
- 日本靜脈 (IV) 設備
- 韓國靜脈 (IV) 設備

第 6 章：歐洲靜脈 (IV) 設備市場展望

市場規模及預測
- 按價值
市佔率及預測
- 按類型
- 按最終用戶
- 按國家/地區
歐洲：國家分析
- 法國
- 德國
- 西班牙
- 義大利
- 英國

第 7 章：北美靜脈 (IV) 設備市場展望

市場規模及預測
- 按價值
市佔率及預測
- 按類型
- 按最終用戶
- 按國家/地區
北美：國家分析
- 美國
- 墨西哥
- 加拿大

第 8 章：南美洲靜脈 (IV) 設備市場展望

市場規模及預測
- 按價值
市佔率及預測
- 按類型
- 按最終用戶
- 按國家/地區
南美洲：國家分析
- 巴西
- 阿根廷
- 哥倫比亞

第 9 章：中東和非洲靜脈 (IV) 設備市場展望

市場規模及預測
- 按價值
市佔率及預測
- 按類型
- 按最終用戶
- 按國家/地區
MEA：國家分析
- 南非靜脈 (IV) 設備
- 沙烏地阿拉伯靜脈 (IV) 設備
- 阿拉伯聯合大公國靜脈 (IV) 設備
- 埃及靜脈 (IV) 設備

第 10 章：市場動態

促進要素
挑戰

第 11 章：市場趨勢與發展

最近的發展
產品發布
併購

第 12 章：全球靜脈 (IV) 設備市場：SWOT 分析

第 13 章：波特的五力分析

產業競爭
新進入者的潛力
供應商的力量
客戶的力量
替代產品的威脅

第14章：競爭格局

3D 系統公司
- Company Snapshot
- Products & Services
- Current Capacity Analysis
- Financials (In case of listed)
- Recent Developments
- SWOT Analysis
3M公司
百特國際
貝克頓迪金森公司
貝朗梅爾松根股份公司
歐洲生命醫療保健列兵。有限公司
亨利沙因公司
ICU 醫療公司
綜合醫學
泰爾茂株式會社
泰利福公司

第 15 章：策略建議

第 16 章：關於我們與免責聲明

簡介目錄

Product Code: 20271

Global Intravenous (IV) Equipment Market has valued at USD 13.57 billion in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 5.27% through 2028. The Global Intravenous (IV) Equipment Market is a dynamic and rapidly evolving sector within the broader healthcare industry, playing a pivotal role in patient care and treatment. Intravenous therapy involves the administration of fluids, medications, and nutrients directly into the bloodstream through a vein, and the corresponding equipment encompasses a wide range of devices designed to facilitate this process. The market is characterized by a growing demand for innovative and advanced IV equipment, driven by the increasing prevalence of chronic diseases, the aging population, and the rising number of surgical procedures globally.

Key factors contributing to the growth of the Global Intravenous Equipment Market include the escalating incidence of diseases such as diabetes, cancer, and cardiovascular disorders, necessitating efficient and precise drug delivery mechanisms. As healthcare systems worldwide focus on improving patient outcomes and minimizing hospital stays, the demand for intravenous therapies has surged. Moreover, technological advancements in IV equipment, such as smart pumps, safety infusion systems, and wireless connectivity, have enhanced the accuracy and safety of drug administration, further fueling market expansion.

The market is segmented into various product categories, including IV catheters, infusion pumps, IV solutions, and accessories. Intravenous catheters, vital for establishing a secure vascular access point, are witnessing innovations aimed at reducing complications and improving patient comfort. Infusion pumps, critical for the controlled and precise delivery of fluids and medications, are undergoing significant enhancements in terms of connectivity, portability, and user interface. IV solutions, comprising a variety of fluids ranging from saline to specialized medications, are experiencing increased demand due to their essential role in patient hydration and medication administration.

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 13.57 Billion
Market Size 2028	USD 18.29 Billion
CAGR 2023-2028	5.27%
Fastest Growing Segment	Asia Pacific
Largest Market	North America

Key Market Drivers

Rising Prevalence of Chronic Diseases

The rising prevalence of chronic diseases is a pivotal factor driving the robust growth of the Global Intravenous (IV) Equipment Market. Chronic diseases, including diabetes, cardiovascular disorders, and cancer, have witnessed a significant surge in incidence worldwide. These conditions often necessitate long-term and intricate medical interventions, with intravenous therapy emerging as a crucial component of their management. The prevalence of chronic diseases is influenced by factors such as sedentary lifestyles, aging populations, and changes in dietary habits. As a result, there is an escalating demand for advanced and efficient intravenous solutions and equipment to facilitate the administration of medications and fluids required for the treatment of chronic conditions.

Intravenous therapy offers a direct and effective route for delivering medications to manage chronic diseases, ensuring precise dosage control and rapid onset of action. The versatility of IV administration makes it a preferred method for various therapeutic interventions, including pain management, chemotherapy, and the administration of antibiotics. Consequently, the Global Intravenous Equipment Market is witnessing increased adoption and innovation to meet the evolving needs of healthcare providers and patients grappling with the challenges posed by the rise in chronic diseases.

Healthcare professionals are increasingly relying on intravenous equipment for its ability to deliver medications directly into the bloodstream, bypassing the digestive system and ensuring a more rapid and predictable therapeutic response. Advanced catheters, infusion pumps, and IV solutions are at the forefront of technological innovation, addressing the unique requirements posed by chronic diseases. The development of smart pumps, for instance, allows for precise and programmable drug delivery, reducing the risk of medication errors and enhancing patient safety, particularly in chronic disease management where medication adherence is critical.

Moreover, the aging population contributes significantly to the prevalence of chronic diseases, as age is a known risk factor for conditions such as diabetes, cardiovascular disorders, and certain types of cancer. With an increasing number of elderly individuals requiring ongoing medical interventions, the demand for intravenous therapies and corresponding equipment is set to grow substantially. This demographic shift emphasizes the instrumental role of IV equipment in providing effective and targeted treatments for chronic conditions prevalent in older age groups.

Aging Population and Increased Surgical Procedures

The Global Intravenous (IV) Equipment Market is experiencing a significant boost from two interrelated factors: the aging population and the increased frequency of surgical procedures. The global demographic landscape is undergoing a transformative shift, with a steady rise in the elderly population. As individuals age, they often contend with a higher incidence of chronic conditions that necessitate advanced medical interventions, including intravenous therapies. This demographic trend has become a key driver for the expanding demand for IV equipment. Elderly individuals frequently require ongoing medical treatments, and intravenous administration is a preferred method for delivering medications, fluids, and nutrients directly into the bloodstream.

The surge in the number of surgical procedures globally is contributing to the growth of the Global Intravenous Equipment Market. Surgical interventions often require intravenous therapy for the administration of anesthesia, pain management, and other critical medications during and after procedures. The precision and control offered by intravenous routes make them indispensable in the surgical setting, enhancing patient safety and optimizing recovery outcomes. As the global healthcare landscape witnesses a rise in both elective and emergency surgeries, the demand for advanced intravenous equipment, such as infusion pumps and catheters, is escalating.

The aging population and increased surgical procedures create a symbiotic relationship that underscores the critical role of IV equipment in modern healthcare. The elderly demographic, with its higher likelihood of requiring surgical interventions, is a driving force behind the sustained demand for intravenous therapies. Moreover, as healthcare systems strive to accommodate the healthcare needs of an aging population, there is a parallel emphasis on improving surgical outcomes through advanced intravenous administration methods. This dual dynamic reinforces the importance of IV equipment as an integral component of comprehensive patient care.

Increased Healthcare Expenditure

The Global Intravenous (IV) Equipment Market is experiencing a significant upswing, buoyed by the substantial increase in healthcare expenditure globally. Governments, private entities, and healthcare organizations are allocating substantial financial resources to enhance healthcare infrastructure, improve patient care, and invest in cutting-edge medical technologies. This heightened focus on healthcare spending has a direct impact on the demand for advanced and sophisticated intravenous (IV) equipment. As healthcare budgets expand, there is a corresponding surge in the adoption of state-of-the-art IV devices, including infusion pumps, catheters, and related accessories.

Increased healthcare expenditure allows for the procurement of the latest IV equipment, enabling healthcare providers to stay abreast of technological advancements and offer optimal patient care. The demand for innovative IV solutions is particularly evident in developed regions such as North America and Europe, where robust healthcare systems and higher healthcare budgets facilitate the widespread adoption of advanced medical technologies. These financial investments contribute to the continuous development of safer, more efficient, and patient-friendly IV equipment, addressing the evolving needs of healthcare professionals and patients alike.

Furthermore, the growing healthcare expenditure is fostering research and development initiatives within the IV equipment sector. Manufacturers are investing in innovation to create devices that not only meet the stringent standards of safety and efficacy but also align with the broader goals of patient-centric healthcare. This includes the development of smart pumps, wireless connectivity features, and ergonomic designs that enhance usability, reduce the risk of errors, and improve overall patient outcomes.

In emerging markets, the increased healthcare expenditure is playing a pivotal role in expanding access to medical services and modern healthcare technologies. As developing countries witness economic growth and allocate more resources to healthcare, there is a rising demand for essential medical equipment, including intravenous devices. The IV equipment market is becoming more inclusive, with a broader range of healthcare settings benefiting from advancements in IV technology.

Key Market Challenges

Cost Constraints and Affordability

Cost constraints and affordability represent significant hurdles for the Global Intravenous (IV) Equipment Market, posing challenges to the widespread adoption of advanced intravenous technologies. The intricate and innovative nature of modern IV equipment, including infusion pumps, smart catheters, and monitoring systems, often comes with a hefty price tag. This presents a barrier for healthcare facilities, particularly in resource-limited regions, where financial constraints impede the seamless integration of state-of-the-art IV solutions.

One of the primary obstacles is the high initial investment required for acquiring advanced IV equipment. Hospitals and healthcare providers, particularly those in developing countries, often operate on tight budgets, making it challenging to allocate substantial funds for the purchase of cutting-edge IV technologies. The upfront costs for these devices can strain financial resources, limiting the ability of healthcare facilities to invest in the latest innovations that could otherwise enhance patient care and safety.

Moreover, ongoing maintenance expenses contribute to the overall cost of IV equipment ownership. Routine maintenance, updates, and servicing are essential to ensure the optimal functioning and longevity of these devices. However, the financial burden associated with maintenance can be prohibitive, especially for smaller healthcare facilities with limited financial resources. This creates a dilemma for healthcare providers, as the long-term benefits of advanced IV equipment must be weighed against the immediate financial constraints they face.

The affordability challenge exacerbates existing disparities in healthcare access between developed and developing regions. While advanced healthcare systems in wealthier countries can readily invest in the latest IV technologies, healthcare facilities in less affluent areas struggle to keep pace. This discrepancy in access hinders the standardization of advanced IV equipment across diverse global healthcare settings, perpetuating disparities in patient care and treatment outcomes.

Safety Concerns and Infections

Safety concerns and the risk of infections stand as formidable challenges hindering the progress of the Global Intravenous (IV) Equipment Market. While intravenous therapies play a pivotal role in modern healthcare, the use of IV catheters carries inherent risks that can impact patient safety and outcomes. Healthcare-associated infections (HAIs) are a persistent concern, and ensuring the sterility of IV equipment is an ongoing challenge that the industry must address to foster confidence among healthcare providers and patients.

The risk of infections associated with IV catheters arises from the breach of the skin barrier, creating a potential entry point for pathogens. Catheter-related bloodstream infections (CRBSIs) pose a significant threat, leading to complications, prolonged hospital stays, and increased healthcare costs. Despite stringent infection control measures, the risk of CRBSIs persists, necessitating continuous efforts to enhance the safety features of IV equipment.

Manufacturers are increasingly focusing on developing catheters with advanced safety features to mitigate infection risks. Antimicrobial coatings, which inhibit the growth of bacteria on the catheter surface, are one avenue of innovation. Additionally, improvements in catheter insertion techniques and securement devices aim to minimize the risk of contamination during the placement and maintenance of IV catheters.

Furthermore, healthcare providers play a crucial role in preventing infections by adhering to strict protocols for catheter insertion, maintenance, and removal. Training programs and ongoing education are essential to ensure that healthcare professionals are well-versed in best practices for preventing catheter-related infections.

Key Market Trends

Focus on Patient-Centric Healthcare

The Global Intravenous (IV) Equipment Market is experiencing a significant boost due to a pronounced shift towards patient-centric healthcare. This transformative trend places the patient at the center of the healthcare experience, influencing the design, functionality, and adoption of intravenous equipment. Recognizing the importance of patient comfort and adherence to treatment plans, manufacturers are increasingly prioritizing user-friendly features in the development of IV devices. Catheters, infusion pumps, and related accessories are being designed with a focus on minimizing discomfort, simplifying usage, and reducing the risk of complications.

Moreover, the emphasis on patient-centric healthcare extends beyond the physical attributes of IV equipment. Healthcare providers are actively seeking solutions that enhance the overall patient experience during intravenous therapies. This involves optimizing treatment regimens to minimize the duration of intravenous sessions, providing clearer communication about treatment plans, and integrating technology that allows for remote monitoring and management of IV therapies. The goal is to empower patients, fostering a sense of engagement and control over their healthcare journey.

The adoption of patient-centric approaches in the Intravenous Equipment Market aligns with broader efforts to improve patient satisfaction and outcomes. As patients become more informed and involved in their healthcare decisions, the demand for IV equipment that aligns with their preferences and needs is on the rise. This trend is particularly significant in chronic disease management, where patients may undergo long-term intravenous treatments. The evolving landscape of patient-centric care is catalyzing innovations that enhance the ease of use, safety, and overall patient satisfaction with IV equipment.

Home infusion therapy, enabled by portable and user-friendly IV equipment, is a notable outcome of the patient-centric healthcare trend. Patients with chronic conditions are increasingly receiving intravenous treatments in the comfort of their homes, reducing the need for prolonged hospital stays. Portable infusion pumps and wearable devices are empowering patients to manage their treatments more independently, contributing to a more patient-centric and decentralized approach to healthcare delivery.

Home Infusion Therapy on the Rise

The Global Intravenous (IV) Equipment Market is experiencing a significant boost from the rising trend of home infusion therapy. Home infusion therapy involves the administration of intravenous medications and fluids in the comfort of patients' homes, marking a notable shift from traditional hospital-based treatments. This trend is transforming the landscape of the IV equipment market, as portable and user-friendly devices become increasingly essential for enabling patients to manage their intravenous therapies independently.

The growing acceptance and adoption of home infusion therapy can be attributed to advancements in IV equipment that prioritize ease of use, portability, and remote monitoring capabilities. Portable infusion pumps, wearable devices, and telehealth solutions are facilitating the transition of certain intravenous treatments from clinical settings to patients' homes. This not only empowers patients to play a more active role in their healthcare but also reduces the burden on healthcare facilities and contributes to cost savings.

The trend towards home infusion therapy is particularly pronounced in the management of chronic conditions, such as autoimmune disorders, cancer, and certain infections, where long-term intravenous treatments are necessary. Patients undergoing home infusion therapy benefit from the flexibility and convenience it offers, avoiding the need for frequent hospital visits and extended stays. This shift aligns with broader healthcare objectives of enhancing patient comfort, improving adherence to treatment plans, and optimizing healthcare resource utilization.

For the Intravenous Equipment Market, the rise of home infusion therapy translates into an increased demand for devices that are well-suited for home use. Manufacturers are responding by developing IV equipment that is compact, easy to operate, and equipped with features that enable remote monitoring by healthcare professionals. Additionally, innovations in catheter design and infusion pump technology are geared towards minimizing the complexity of home-based intravenous therapies, ensuring safety, and enhancing the overall patient experience.

Segmental Insights

Type Insights

Based on the Type, Infusion pumps emerged as the dominant segment in the global market for Global Intravenous (IV) Equipment in 2022. Infusion pumps are designed to provide precise control over the rate and volume of medication administered intravenously. This accuracy is critical, especially in situations where the dosage must be carefully controlled to achieve therapeutic outcomes and avoid potential complications. The ability to deliver medications in a controlled manner contributes to the safety and effectiveness of intravenous therapies. Infusion pumps are versatile and can be used for a wide range of intravenous therapies, including antibiotic administration, pain management, chemotherapy, and parenteral nutrition. This versatility makes infusion pumps indispensable in diverse healthcare settings, from hospitals to home care, contributing to their widespread adoption and demand.

End-User Insights

Based on the End-User, Hospitals emerged as the dominant segment in the global market for Global Intravenous (IV) Equipment Market in 2022. Hospitals generally handle a large volume and diverse range of patients and medical conditions. The extensive scope of medical services provided by hospitals, including emergency care, surgeries, critical care, and various specialized treatments, necessitates a significant demand for intravenous therapies. IV equipment, such as infusion pumps, catheters, and administration sets, is essential for delivering medications, fluids, and nutrients to patients undergoing a wide array of treatments. Hospitals serve as comprehensive healthcare facilities that offer a broad spectrum of medical services, covering diagnostics, surgeries, inpatient care, and outpatient services. The varied nature of healthcare services provided within a hospital setting requires the utilization of a diverse range of IV equipment to meet the specific needs of different medical departments and patient populations.

Regional Insights

North America emerged as the dominant player in the Global Intravenous (IV) Equipment Market in 2022, holding the largest market share. The United States and Canada have advanced healthcare systems with well-established regulatory frameworks. This allows for the efficient adoption and integration of the latest medical technologies, including intravenous equipment. North America typically has a high level of healthcare expenditure. The significant investment in healthcare infrastructure, research and development, and medical technology contributes to the dominance of the region in the global market.

Key Market Players

3D Systems, Inc.

3M Company

Baxter International

Becton, Dickinson and Company

B. Braun Melsungen AG

EuroLife Healthcare Pvt. Ltd

Henry Schein, Inc

ICU Medical, Inc

Polymedicure

Terumo Corporation

Teleflex Incorporated

Report Scope:

In this report, the Global Intravenous (IV) Equipment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Global Intravenous (IV) Equipment Market, By Type:

IV Catheters
Infusion Pumps
Securement Devices
Administration Sets
Drip Chambers
Other Types

Global Intravenous (IV) Equipment Market, By End-User:

Hospitals
Ambulatory Surgical Centers
Other End-Users

Global Intravenous (IV) Equipment Market, By Region:

North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
Turkey
Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Intravenous (IV) Equipment Market.

Available Customizations:

Global Intravenous (IV) Equipment Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Global Intravenous (IV) Equipment Market Outlook

4.1. Market Size & Forecast
- 4.1.1. By Value
4.2. Market Share & Forecast
- 4.2.1. By Type (IV Catheters, Infusion Pumps, Securement Devices, Administration Sets, Drip Chambers, Other Types)
- 4.2.2. By End-User (Hospitals, Ambulatory Surgical Centers, Other End-Users)
- 4.2.3. By Region
- 4.2.4. By Company (2022)
4.3. Market Map
- 4.3.1. By Type
- 4.3.2. By End-User
- 4.3.3. By Region

5. Asia Pacific Intravenous (IV) Equipment Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Type
- 5.2.2. By End-User
- 5.2.3. By Country
5.3. Asia Pacific: Country Analysis
- 5.3.1. China Intravenous (IV) Equipment Market Outlook
  - 5.3.1.1. Market Size & Forecast
    - 5.3.1.1.1. By Value
  - 5.3.1.2. Market Share & Forecast
    - 5.3.1.2.1. By Type
    - 5.3.1.2.2. By End-User
- 5.3.2. India Intravenous (IV) Equipment Market Outlook
  - 5.3.2.1. Market Size & Forecast
    - 5.3.2.1.1. By Value
  - 5.3.2.2. Market Share & Forecast
    - 5.3.2.2.1. By Type
    - 5.3.2.2.2. By End-User
- 5.3.3. Australia Intravenous (IV) Equipment Market Outlook
  - 5.3.3.1. Market Size & Forecast
    - 5.3.3.1.1. By Value
  - 5.3.3.2. Market Share & Forecast
    - 5.3.3.2.1. By Type
    - 5.3.3.2.2. By End-User
- 5.3.4. Japan Intravenous (IV) Equipment Market Outlook
  - 5.3.4.1. Market Size & Forecast
    - 5.3.4.1.1. By Value
  - 5.3.4.2. Market Share & Forecast
    - 5.3.4.2.1. By Type
    - 5.3.4.2.2. By End-User
- 5.3.5. South Korea Intravenous (IV) Equipment Market Outlook
  - 5.3.5.1. Market Size & Forecast
    - 5.3.5.1.1. By Value
  - 5.3.5.2. Market Share & Forecast
    - 5.3.5.2.1. By Type
    - 5.3.5.2.2. By End-User

6. Europe Intravenous (IV) Equipment Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By End-User
- 6.2.3. By Country
6.3. Europe: Country Analysis
- 6.3.1. France Intravenous (IV) Equipment Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Type
    - 6.3.1.2.2. By End-User
- 6.3.2. Germany Intravenous (IV) Equipment Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Type
    - 6.3.2.2.2. By End-User
- 6.3.3. Spain Intravenous (IV) Equipment Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Type
    - 6.3.3.2.2. By End-User
- 6.3.4. Italy Intravenous (IV) Equipment Market Outlook
  - 6.3.4.1. Market Size & Forecast
    - 6.3.4.1.1. By Value
  - 6.3.4.2. Market Share & Forecast
    - 6.3.4.2.1. By Type
    - 6.3.4.2.2. By End-User
- 6.3.5. United Kingdom Intravenous (IV) Equipment Market Outlook
  - 6.3.5.1. Market Size & Forecast
    - 6.3.5.1.1. By Value
  - 6.3.5.2. Market Share & Forecast
    - 6.3.5.2.1. By Type
    - 6.3.5.2.2. By End-User

7. North America Intravenous (IV) Equipment Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By End-User
- 7.2.3. By Country
7.3. North America: Country Analysis
- 7.3.1. United States Intravenous (IV) Equipment Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Type
    - 7.3.1.2.2. By End-User
- 7.3.2. Mexico Intravenous (IV) Equipment Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Type
    - 7.3.2.2.2. By End-User
- 7.3.3. Canada Intravenous (IV) Equipment Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Type
    - 7.3.3.2.2. By End-User

8. South America Intravenous (IV) Equipment Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By End-User
- 8.2.3. By Country
8.3. South America: Country Analysis
- 8.3.1. Brazil Intravenous (IV) Equipment Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Type
    - 8.3.1.2.2. By End-User
- 8.3.2. Argentina Intravenous (IV) Equipment Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Type
    - 8.3.2.2.2. By End-User
- 8.3.3. Colombia Intravenous (IV) Equipment Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Type
    - 8.3.3.2.2. By End-User

9. Middle East and Africa Intravenous (IV) Equipment Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By End-User
- 9.2.3. By Country
9.3. MEA: Country Analysis
- 9.3.1. South Africa Intravenous (IV) Equipment Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Type
    - 9.3.1.2.2. By End-User
- 9.3.2. Saudi Arabia Intravenous (IV) Equipment Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Type
    - 9.3.2.2.2. By End-User
- 9.3.3. UAE Intravenous (IV) Equipment Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Type
    - 9.3.3.2.2. By End-User
- 9.3.4. Egypt Intravenous (IV) Equipment Market Outlook
  - 9.3.4.1. Market Size & Forecast
    - 9.3.4.1.1. By Value
  - 9.3.4.2. Market Share & Forecast
    - 9.3.4.2.1. By Type
    - 9.3.4.2.2. By End-User

10. Market Dynamics

10.1. Drivers
10.2. Challenges

11. Market Trends & Developments

11.1. Recent Developments
11.2. Product Launches
11.3. Mergers & Acquisitions

12. Global Intravenous (IV) Equipment Market: SWOT Analysis

13. Porter's Five Forces Analysis

13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Product

14. Competitive Landscape

14.1. 3D Systems, Inc.
- 14.1.1. Company Snapshot
- 14.1.2. Products & Services
- 14.1.3. Current Capacity Analysis
- 14.1.4. Financials (In case of listed)
- 14.1.5. Recent Developments
- 14.1.6. SWOT Analysis
14.2. 3M Company
14.3. Baxter International
14.4. Becton, Dickinson and Company
14.5. B. Braun Melsungen AG
14.6. EuroLife Healthcare Pvt. Ltd
14.7. Henry Schein, Inc
14.8. ICU Medical, Inc
14.9. Polymedicure
14.10. Terumo Corporation
14.11. Teleflex Incorporated